| |
| |
|
| Insider
Information: |
Ciaffoni Joseph |
| Relationship: |
President and CEO, Dir... |
| City: |
Atlanta |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
444,867 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$16,593,539 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
444,867 |
|
|
| Total
Value |
$16,593,539 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Collegium Pharmaceutical, Inc |
COLL |
President and CEO, Dir... |
2024-02-12 |
444,867 |
2017-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2024-02-12 |
4 |
D |
$33.70 |
$4,342,818 |
D/D |
(128,867) |
444,867 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
298,734 |
573,734 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-12-21 |
4 |
AS |
$30.38 |
$132,377 |
D/D |
(4,357) |
275,000 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-12-21 |
4 |
OE |
$21.34 |
$92,978 |
D/D |
4,357 |
279,357 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-12-20 |
4 |
AS |
$30.40 |
$804,210 |
D/D |
(26,454) |
275,000 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-12-20 |
4 |
OE |
$21.34 |
$564,528 |
D/D |
26,454 |
301,454 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-12-19 |
4 |
AS |
$30.03 |
$435,942 |
D/D |
(14,516) |
275,000 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-12-19 |
4 |
OE |
$21.34 |
$309,771 |
D/D |
14,516 |
289,516 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-12-18 |
4 |
OE |
$21.34 |
$593,209 |
D/D |
27,798 |
302,798 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-12-18 |
4 |
AS |
$30.04 |
$834,935 |
D/D |
(27,798) |
275,000 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-06-02 |
4 |
AS |
$21.58 |
$675,424 |
D/D |
(31,272) |
275,000 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-06-01 |
4 |
AS |
$22.09 |
$690,758 |
D/D |
(31,272) |
306,272 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-05-31 |
4 |
AS |
$21.87 |
$683,797 |
D/D |
(31,272) |
337,544 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-05-30 |
4 |
AS |
$21.90 |
$684,907 |
D/D |
(31,271) |
368,816 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-02-13 |
4 |
OE |
$15.90 |
$178,875 |
D/D |
11,250 |
411,337 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-02-13 |
4 |
AS |
$26.88 |
$302,400 |
D/D |
(11,250) |
400,087 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-02-10 |
4 |
D |
$26.75 |
$2,778,175 |
D/D |
(103,857) |
400,087 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2023-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
255,194 |
503,944 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2022-12-27 |
4 |
AS |
$23.65 |
$52,341 |
D/D |
(2,204) |
248,750 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2022-12-23 |
4 |
AS |
$23.00 |
$3,381 |
D/D |
(147) |
250,954 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2022-12-22 |
4 |
AS |
$23.00 |
$2,530 |
D/D |
(110) |
251,101 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2022-12-21 |
4 |
AS |
$23.11 |
$169,466 |
D/D |
(7,333) |
251,211 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2022-12-20 |
4 |
AS |
$23.07 |
$216,281 |
D/D |
(9,375) |
258,544 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2022-12-19 |
4 |
AS |
$23.01 |
$26,093 |
D/D |
(1,134) |
267,919 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
President and CEO |
• • – |
2022-12-02 |
4 |
AS |
$23.07 |
$1,255,008 |
D/D |
(54,400) |
269,053 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
